当前位置:首页 - 行情中心 - 九强生物(300406) - 财务分析

九强生物

(300406)

  

流通市值:62.39亿  总市值:86.48亿
流通股本:4.24亿   总股本:5.88亿

九强生物(300406)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.72亿元,每股收益0.63元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益396454.83万元,未分配利润263576.31万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产545716.69万元,负债149261.86万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,237,396,355.82821,722,324.81393,894,885.381,741,626,675.37
营业总成本793,399,425.93518,454,199.71252,157,863.841,152,367,616.41
营业利润443,677,728.79302,644,933.66144,380,239.45593,876,387.22
利润总额441,532,898.97300,574,955.91142,407,950.93593,554,564.06
净利润372,402,279249,587,292.26120,219,484.04522,069,659.87
其他综合收益-163,841.94110,421.3637,868.49218,516.48
综合收益总额372,238,437.06249,697,713.62120,257,352.53522,288,176.35
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计2,597,126,673.952,604,421,562.752,743,372,108.322,334,266,497.33
非流动资产合计2,860,040,238.912,694,255,324.262,534,729,999.442,841,482,308.99
资产总计5,457,166,912.865,298,676,887.015,278,102,107.765,175,748,806.32
流动负债合计287,588,481.79251,359,490.96247,582,649.08297,115,778.07
非流动负债合计1,205,030,145.961,197,546,091.231,188,221,799.981,157,082,871.61
负债合计1,492,618,627.751,448,905,582.191,435,804,449.061,454,198,649.68
归属于母公司股东权益合计3,970,743,202.73,855,551,704.933,847,752,663.853,724,591,909.76
股东权益合计3,964,548,285.113,849,771,304.823,842,297,658.73,721,550,156.64
负债和股东权益合计5,457,166,912.865,298,676,887.015,278,102,107.765,175,748,806.32
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计1,355,254,133.75897,787,083.25413,326,787.631,805,262,732.03
经营活动现金流出小计951,980,056.32675,320,318.53395,775,987.111,220,169,237.56
经营活动产生的现金流量净额403,274,077.43222,466,764.7217,550,800.52585,093,494.47
投资活动现金流入小计274,149,272.89324,878,672.89314,730,786.14357,085,797.82
投资活动现金流出小计236,089,077.7183,127,236.4739,384,851.07484,300,542.76
投资活动产生的现金流量净额38,060,195.18241,751,436.42275,345,935.07-127,214,744.94
筹资活动现金流入小计26,176,061.3622,823,499.6522,285,066.76146,884,254.14
筹资活动现金流出小计184,779,404.88157,541,550.915,153,782.09221,641,455.53
筹资活动产生的现金流量净额-158,603,343.52-134,718,051.2617,131,284.67-74,757,201.39
汇率变动对现金及现金等价物的影响197,327.3528,579.05-284,324.29196,198.38
现金及现金等价物净增加额282,928,256.44329,528,728.93309,743,695.97383,317,746.52
期末现金及现金等价物余额994,558,736.911,041,159,209.41,021,374,176.44711,630,480.47
最新报告期:2024-10-28
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
中泰证券于佳喜,祝嘉琦,谢木青0.920.991.162024-10-28
TOP↑